Evidence map›Paper›PMID 33721725›Full record

ReviewCurrent opinion in immunology2021

Genetic and immunological basis of human African trypanosomiasis.

Etienne Pays, Derek P Nolan

Abstract readReview
In one paragraph

Review in Current opinion in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. RNA Polymerase 1 inhibitors against African trypanosomesAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Interferon-Science (New York, N.Y.) · 2024
    Review
  5. Advancing age grading techniques forBiology methods & protocols · 2024
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Etienne PaysLaboratory of Molecular Parasitology, IBMM, Université Libre de Bruxelles, 6041 Gosselies, Belgium. Electronic address: epays@ulb.ac.be.
Derek P NolanSchool of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Human African trypanosomiasis, or sleeping sickness, results from infection by two subspecies of the protozoan flagellate parasite Trypanosoma brucei, termed Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, prevalent in western and eastern Africa respectively. These subspecies escape the trypanolytic potential of human serum, which efficiently acts against the prototype species Trypanosoma brucei brucei, responsible for the Nagana disease in cattle. We review the various strategies and components used by trypanosomes to counteract the immune defences of their host, highlighting the adaptive genomic evolution that occurred in both parasite and host to take the lead in this battle. The main parasite surface antigen, named Variant Surface Glycoprotein or VSG, appears to play a key role in different processes involved in the dialogue with the host.

Indexed as

Genetic Predisposition to DiseaseAdaptive ImmunityApolipoprotein L1Disease ResistanceDisease SusceptibilityGene Expression RegulationGenetic VariationHost-Parasite InteractionsHumansImmunity, InnateMembrane GlycoproteinsProtein BindingProtozoan ProteinsTrypanosoma brucei gambienseTrypanosomiasis, AfricanAPOL1 protein, humanApolipoprotein L1Membrane GlycoproteinsProtozoan Proteins

Identifiers

PMID33721725
PMCPMC8589022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.